Top 10 Drug Discovery and Development Solution Providers in Europe - 2019
pharmatechoutlook
Origenis: A NEW APPROACH TO SMALL MOLECULE DRUG DISCOVERY

Top 10 Drug Discovery and Development Solution Providers in Europe - 2019

In the pharmaceutical industry, the process of developing nascent drugs to cure a disease is quite long, costly, and at the same time uncertain. In light of this, many experts in this space cite that the costs of developing new drugs can be reduced by the use of new technologies and with a deep understanding of biology. Albeit the objectives of drug delivery remain the same, the methods and techniques used in drug development continue to experience radical changes. In a nutshell, the standard approach to drug discovery is to identify a single molecular disease target and subsequently identify a compound that interacts and modulates with high specificity. Today, majority of the innovation reinvigorating the drug development methodologies seeks to access and integrate more information – about targets, compounds, and disease phenotypes. Next, the increasing size of chemical libraries and high throughput screening (HTS) technologies have enabled thousands or millions of compounds to be screened and the concomitant increase in compounds have supplemented the urgency for the bioanalysis of metabolites, and a need for faster turnaround.

To assist CIOs maneuver in the right direction while working on Drug Discovery and Development, a distinguished panel of CEOs, CIOs, VCs, and analysts along with the Pharma Tech Outlook’s editorial board has selected the leading Drug Discovery and Development service providers in Europe. The companies featured in this edition demonstrate an ability to develop innovative technologies combined with outstanding customer service.

We present to you Top 10 Drug Discovery and Development Solution Providers in Europe - 2019

Company Logo Company Name Company Description
BC Platforms Provides powerful genomic data management and analysis solutions that leverage the convergence of genomics and healthcare information technologies
Evotech Helps in developing partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies
GENFIT GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions
Human Metabolome Technologies (HMT) A global metabolomics CRO and manufacturer of capillary electrophoresis-mass spectrometry (CE-MS)-based metabolome analysis
InSphero Provides advanced, easy-to-use 3D tissue-based assay solutions for predictive compound classification to clients in the pharmaceutical, biotech & cosmetic industries
LEUKOCARE AG Provides a formulation technology platform for the increased stability and improved protection of biopharmaceuticals
Micronit Provides innovative lab-on-a-chip and MEMS solutions to help its customers improve their products and research, contributing to the quality of life
Origenis The biopharmaceutical company discovers highly selective novel small molecule medicines for a variety of targets and diseases for further development at partners
Pivot Park Screening Centre Provides an open, innovative setting for the automation of extensive cellular and biochemical in-vitro screening experiments and High Throughput Screening (HTS) service
Systasy Bioscience Provides innovative products and services to enable pharma companies optimize and accelerate their drug discovery processes